Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Change in Intangibles (2022 - 2026)

Alvotech's (ALVO) quarterly Change in Intangibles came in at -$16.9 million in Q2 2026, down 12.8% on a YoY basis from -$19.4 million in Q2 2025, and up 56.72% quarter-over-quarter from -$39.1 million in Q1 2026.

Analysis

Alvotech (ALVO) Change in Intangibles (2022 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Change in Intangibles for 5 consecutive years, with -$16.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Intangibles fell 12.8% year-over-year to -$16.9 million; the trailing twelve-month figure through Jun 2026 stood at -$72.4 million (down 282.63% YoY), and the FY2025 full-year result was -$31.7 million, down 848.16% from the prior year.
  • Change in Intangibles rose to -$16.9 million in Q2 2026 per ALVO's latest filing, from -$39.1 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at -$183000.0 in Q1 2025 and bottomed at -$39.1 million in Q1 2026.
  • Historically, Change in Intangibles has averaged -$9.0 million across 5 years, with a median of -$7.0 million in 2025.
  • The sharpest annual moves came in 2024 and 2026: Change in Intangibles jumped 74.78% in 2024, then sank 21240.44% in 2026.
  • Over 5 years, Change in Intangibles stood at -$11.1 million in 2022, then retreated by 19.03% to -$13.2 million in 2023, then surged by 74.78% to -$3.3 million in 2024, then plunged by 110.45% to -$7.0 million in 2025, then tumbled by 140.54% to -$16.9 million in 2026.
  • According to Business Quant data, Change in Intangibles over the past three periods registered -$16.9 million, -$39.1 million, and -$7.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 22.34 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -16.90 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.90 Mn
Mar 31, 2026 -39.05 Mn
Dec 31, 2025 -7.03 Mn
Sep 30, 2025 -9.46 Mn
Jun 30, 2025 -14.99 Mn
Mar 31, 2025 -183,000.00
Dec 31, 2024 -3.34 Mn
Sep 30, 2024 -427,000.00
Jun 30, 2024 -887,000.00
Mar 31, 2024 -543,000.00
Dec 31, 2023 -13.24 Mn
Jun 30, 2023 -216,000.00
Dec 31, 2022 -11.12 Mn